Cargando…
The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles
Catecholaminergic polymorphic ventricular tachycardia (CPVT) predisposes to ventricular arrhythmia due to altered Ca(2+) homeostasis and can arise from ryanodine receptor (RyR2) mutations including RyR2-P2328S. Previous reports established that homozygotic murine RyR2-P2328S (RyR2(S/S)) hearts show...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792352/ https://www.ncbi.nlm.nih.gov/pubmed/26545784 http://dx.doi.org/10.1007/s00424-015-1750-0 |
_version_ | 1782421226129457152 |
---|---|
author | Ning, Feifei Luo, Ling Ahmad, Shiraz Valli, Haseeb Jeevaratnam, Kamalan Wang, Tingzhong Guzadhur, Laila Yang, Dandan Fraser, James A. Huang, Christopher L.-H. Ma, Aiqun Salvage, Samantha C. |
author_facet | Ning, Feifei Luo, Ling Ahmad, Shiraz Valli, Haseeb Jeevaratnam, Kamalan Wang, Tingzhong Guzadhur, Laila Yang, Dandan Fraser, James A. Huang, Christopher L.-H. Ma, Aiqun Salvage, Samantha C. |
author_sort | Ning, Feifei |
collection | PubMed |
description | Catecholaminergic polymorphic ventricular tachycardia (CPVT) predisposes to ventricular arrhythmia due to altered Ca(2+) homeostasis and can arise from ryanodine receptor (RyR2) mutations including RyR2-P2328S. Previous reports established that homozygotic murine RyR2-P2328S (RyR2(S/S)) hearts show an atrial arrhythmic phenotype associated with reduced action potential (AP) conduction velocity and sodium channel (Na(v)1.5) expression. We now relate ventricular arrhythmogenicity and slowed AP conduction in RyR2(S/S) hearts to connexin-43 (Cx43) and Na(v)1.5 expression and Na(+) current (I(Na)). Stimulation protocols applying extrasystolic S2 stimulation following 8 Hz S1 pacing at progressively decremented S1S2 intervals confirmed an arrhythmic tendency despite unchanged ventricular effective refractory periods (VERPs) in Langendorff-perfused RyR2(S/S) hearts. Dynamic pacing imposing S1 stimuli then demonstrated that progressive reductions of basic cycle lengths (BCLs) produced greater reductions in conduction velocity at equivalent BCLs and diastolic intervals in RyR2(S/S) than WT, but comparable changes in AP durations (APD(90)) and their alternans. Western blot analyses demonstrated that Cx43 protein expression in whole ventricles was similar, but Na(v)1.5 expression in both whole tissue and membrane fractions were significantly reduced in RyR2(S/S) compared to wild-type (WT). Loose patch-clamp studies similarly demonstrated reduced I(Na) in RyR2(S/S) ventricles. We thus attribute arrhythmogenesis in RyR2(S/S) ventricles resulting from arrhythmic substrate produced by reduced conduction velocity to downregulated Na(v)1.5 reducing I(Na), despite normal determinants of repolarization and passive conduction. The measured changes were quantitatively compatible with earlier predictions of linear relationships between conduction velocity and the peak I(Na) of the AP but nonlinear relationships between peak I(Na) and maximum Na(+) permeability. |
format | Online Article Text |
id | pubmed-4792352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-47923522016-04-09 The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles Ning, Feifei Luo, Ling Ahmad, Shiraz Valli, Haseeb Jeevaratnam, Kamalan Wang, Tingzhong Guzadhur, Laila Yang, Dandan Fraser, James A. Huang, Christopher L.-H. Ma, Aiqun Salvage, Samantha C. Pflugers Arch Molecular and Cellular Mechanisms of Disease Catecholaminergic polymorphic ventricular tachycardia (CPVT) predisposes to ventricular arrhythmia due to altered Ca(2+) homeostasis and can arise from ryanodine receptor (RyR2) mutations including RyR2-P2328S. Previous reports established that homozygotic murine RyR2-P2328S (RyR2(S/S)) hearts show an atrial arrhythmic phenotype associated with reduced action potential (AP) conduction velocity and sodium channel (Na(v)1.5) expression. We now relate ventricular arrhythmogenicity and slowed AP conduction in RyR2(S/S) hearts to connexin-43 (Cx43) and Na(v)1.5 expression and Na(+) current (I(Na)). Stimulation protocols applying extrasystolic S2 stimulation following 8 Hz S1 pacing at progressively decremented S1S2 intervals confirmed an arrhythmic tendency despite unchanged ventricular effective refractory periods (VERPs) in Langendorff-perfused RyR2(S/S) hearts. Dynamic pacing imposing S1 stimuli then demonstrated that progressive reductions of basic cycle lengths (BCLs) produced greater reductions in conduction velocity at equivalent BCLs and diastolic intervals in RyR2(S/S) than WT, but comparable changes in AP durations (APD(90)) and their alternans. Western blot analyses demonstrated that Cx43 protein expression in whole ventricles was similar, but Na(v)1.5 expression in both whole tissue and membrane fractions were significantly reduced in RyR2(S/S) compared to wild-type (WT). Loose patch-clamp studies similarly demonstrated reduced I(Na) in RyR2(S/S) ventricles. We thus attribute arrhythmogenesis in RyR2(S/S) ventricles resulting from arrhythmic substrate produced by reduced conduction velocity to downregulated Na(v)1.5 reducing I(Na), despite normal determinants of repolarization and passive conduction. The measured changes were quantitatively compatible with earlier predictions of linear relationships between conduction velocity and the peak I(Na) of the AP but nonlinear relationships between peak I(Na) and maximum Na(+) permeability. Springer Berlin Heidelberg 2015-11-06 2016 /pmc/articles/PMC4792352/ /pubmed/26545784 http://dx.doi.org/10.1007/s00424-015-1750-0 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Molecular and Cellular Mechanisms of Disease Ning, Feifei Luo, Ling Ahmad, Shiraz Valli, Haseeb Jeevaratnam, Kamalan Wang, Tingzhong Guzadhur, Laila Yang, Dandan Fraser, James A. Huang, Christopher L.-H. Ma, Aiqun Salvage, Samantha C. The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles |
title | The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles |
title_full | The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles |
title_fullStr | The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles |
title_full_unstemmed | The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles |
title_short | The RyR2-P2328S mutation downregulates Na(v)1.5 producing arrhythmic substrate in murine ventricles |
title_sort | ryr2-p2328s mutation downregulates na(v)1.5 producing arrhythmic substrate in murine ventricles |
topic | Molecular and Cellular Mechanisms of Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792352/ https://www.ncbi.nlm.nih.gov/pubmed/26545784 http://dx.doi.org/10.1007/s00424-015-1750-0 |
work_keys_str_mv | AT ningfeifei theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT luoling theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT ahmadshiraz theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT vallihaseeb theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT jeevaratnamkamalan theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT wangtingzhong theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT guzadhurlaila theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT yangdandan theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT fraserjamesa theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT huangchristopherlh theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT maaiqun theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT salvagesamanthac theryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT ningfeifei ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT luoling ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT ahmadshiraz ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT vallihaseeb ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT jeevaratnamkamalan ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT wangtingzhong ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT guzadhurlaila ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT yangdandan ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT fraserjamesa ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT huangchristopherlh ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT maaiqun ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles AT salvagesamanthac ryr2p2328smutationdownregulatesnav15producingarrhythmicsubstrateinmurineventricles |